Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis
Clinical trial NCT03972280 · COMPLETED
Trial details
- NCT number
- NCT03972280
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-04
- Primary completion
- 2022-10-04
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.